Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of treatment for liver disease. The Unit makes small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis.
This information is reserved for PitchBook Platform users. To explore Phenex Pharmaceuticals (FarnesoidX receptor program)‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.